Tidal Investments’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.26M Buy
37,064
+30,172
+438% +$5.86M 0.02% 674
2025
Q4
$1.2M Buy
6,892
+2,826
+70% +$515K ﹤0.01% 1178
2025
Q3
$775K Buy
4,066
+968
+31% +$172K ﹤0.01% 1337
2025
Q2
$556K Buy
3,098
+641
+26% +$111K ﹤0.01% 1329
2025
Q1
$416K Buy
2,457
+614
+33% +$101K ﹤0.01% 1413
2024
Q4
$278K Sell
1,843
-2,532
-58% -$394K ﹤0.01% 1624
2024
Q3
$679K Sell
4,375
-4,656
-52% -$695K 0.01% 1229
2024
Q2
$1.24M Sell
9,031
-1,687
-16% -$231K 0.02% 785
2024
Q1
$1.43M Buy
10,718
+7,350
+218% +$954K 0.02% 707
2023
Q4
$464K Buy
3,368
+227
+7% +$29.8K 0.01% 975
2023
Q3
$383K Buy
3,141
+493
+19% +$65.7K 0.01% 967
2023
Q2
$372K Sell
2,648
-726
-22% -$100K 0.01% 952
2023
Q1
$477K Sell
3,374
-2,159
-39% -$309K 0.02% 782
2022
Q4
$866K Sell
5,533
-7,209
-57% -$1.04M 0.03% 488
2022
Q3
$1.55M Buy
12,742
+1,236
+11% +$163K 0.06% 274
2022
Q2
$1.53M Buy
11,506
+3,854
+50% +$525K 0.06% 282
2022
Q1
$1.05M Buy
7,652
+855
+13% +$119K 0.03% 410
2021
Q4
$1.18M Buy
6,797
+3,986
+142% +$606K 0.04% 359
2021
Q3
$409K Buy
2,811
+999
+55% +$146K 0.02% 562
2021
Q2
$239K Buy
+1,812
New +$237K 0.01% 644

Other funds holding DGX

Tidal Investments's DGX Position: Q1 2026 in Review

Tidal Investments increased its Quest Diagnostics (DGX) stake by 438% in Q1 2026, buying an estimated $5.86M and bringing the position to 37,064 shares worth $7.26M. The position accounts for 0.02% of the portfolio, ranked #674.

Tidal Investments first reported a position in DGX in Q2 2021 and has held it in 20 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Tidal Investments held 37,064 shares of Quest Diagnostics worth $7.26M as of Q1 2026.
  • Tidal Investments bought 30,172 Quest Diagnostics shares in Q1 2026, an estimated $5.86M.
  • Quest Diagnostics made up 0.02% of Tidal Investments's portfolio in Q1 2026, its #674 holding.
  • Tidal Investments first reported a position in Quest Diagnostics in Q2 2021 and has held it in 20 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.